Profilo
Richard Porter was the founder of uniQure France SAS, serving as Chief Executive Officer & Director since 2019.
Dr. Porter is currently the Chief Business & Scientific Officer at uniQure NV, starting in 2021.
Former positions include General Manager-Emerging Business Unit at Shire Plc from 2011 to 2014, Global Head-Scientific Business Strategy at Roche Group from 2014 to 2016, Chief Operating Officer at Therachon AG from 2016 to 2019, and General Manager at Corlieve Therapeutics AG.
Education includes a doctorate from The University of Southampton.
Posizioni attive di Richard Porter
| Società | Posizione | Inizio |
|---|---|---|
| UNIQURE N.V. | Direttore Tecnico/Scientifico/R&S | 05/10/2023 |
Precedenti posizioni note di Richard Porter
| Società | Posizione | Fine |
|---|---|---|
Therachon AG | Direttore operativo | 01/07/2019 |
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Direttore Tecnico/Scientifico/R&S | 01/08/2016 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Corporate Officer/Principal | 01/02/2014 |
Corlieve Therapeutics AG | Amministratore Delegato | - |
Corlieve Therapeutics SAS
Corlieve Therapeutics SAS Pharmaceuticals: MajorHealth Technology Develops transformational medicines for neurological diseases | Fondatore | - |
Formazione di Richard Porter
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
The University of Southampton
The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
uniQure NV
uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Therachon AG | |
Corlieve Therapeutics SAS
Corlieve Therapeutics SAS Pharmaceuticals: MajorHealth Technology Develops transformational medicines for neurological diseases | Health Technology |
Corlieve Therapeutics AG |
















